Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation - Takeaways - MDSpire

Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation

he Mark Foundation for Cancer Research has named Dr. Mariella Filbin, Research Co-Director of the Pediatric Neuro-Oncology Program at Dana-Farber Cancer Institute, the recipient of the 2026 Emerging Leader Award, recognizing her innovative work to advance treatment options for aggressive childhood brain tumors.

  • By

  • January 14, 2026

  • 2 min

Share

  • 1

    Dr. Mariella Filbin received the 2026 Emerging Leader Award from The Mark Foundation for her work on childhood brain tumors.

  • 2

    She will receive $750,000 over three years for her research on DNA repair in diffuse midline gliomas.

  • 3

    Dr. Filbin's research aims to understand how tumors resist therapy and improve treatment outcomes for pediatric patients.

  • 4

    The Mark Foundation's award program supports early-career scientists with innovative cancer research projects.

  • 5

    Diffuse midline gliomas are rare brain tumors with limited treatment options, primarily affecting children and young adults.

Original Source(s)

Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation

  • by

  • January 14, 2026

Related Content

Retrospective Characterization of Specialized Palliative Care in Patients With Gliomas

Patients with gliomas face significant challenges in daily life due to rapidly progressing neurological and cognitive symptoms. This study evaluated referral processes for specialized palliative care and interdisciplinary services used by patients with gliomas and their caregivers in Denmark.

Immune interception in cancer: prioritizing vaccination in high-risk and premalignant settings

A cell death program–based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma